Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 14;11(12):3418.
doi: 10.3390/jcm11123418.

Surgery for Aortic Prosthetic Valve Endocarditis in the Transcatheter Era

Shekhar Saha  1   2 , Ahmad Ali  1   2 , Philipp Schnackenburg  1   2 , Konstanze Maria Horke  1   2 , Andreas Oberbach  1   2   3 , Nadine Schlichting  3   4 , Sebastian Sadoni  1   2 , Konstantinos Rizas  5 , Daniel Braun  5 , Maximilian Luehr  1   6 , Erik Bagaev  1   7 , Christian Hagl  1   2 , Dominik Joskowiak  1   2
Affiliations

Surgery for Aortic Prosthetic Valve Endocarditis in the Transcatheter Era

Shekhar Saha et al. J Clin Med. .

Abstract

Objectives: As surgical experience with infective endocarditis following transcatheter aortic valve replacement is scarce, this study compared the perioperative and short-term outcomes of patients suffering from endocarditis following surgical aortic valve replacement and transcatheter aortic valve replacement. Methods: Between January 2013 and December 2020, 468 consecutive patients were admitted to our center for surgery for IE. Among them, 98 were operated on for endocarditis following surgical aortic valve replacement and 22 for endocarditis following transcatheter aortic valve replacement. Results: The median EuroSCORE II (52.1 (40.6-62.0) v/s 45.4 (32.6-58.1), p = 0.207) and STS-PROM (1.8 (1.6-2.1) v/s 1.9 (1.4-2.2), p = 0.622) were comparable. Endocarditis following transcatheter aortic valve replacement accounted for 13.7% of the aortic prosthetic valve endocarditis between 2013 and 2015; this increased to 26.9% in the years 2019 and 2020.Concomitant procedures were performed in 35 patients (29.2%). The operative mortality was 26.5% in the endocarditis following surgical aortic valve replacement group and 9.1% in the endocarditis following transcatheter aortic valve replacement group (p = 0.098). Upon follow-up, survival at 6 months was found to be 98% in the group with endocarditis following surgical aortic valve replacement and 89% in the group with endocarditis following transcatheter aortic valve replacement (p = 0.081). Conclusions: Patients suffering from endocarditis following surgical aortic valve replacement and transcatheter aortic valve replacement present with comparable risk profiles and can be surgically treated with comparable results. Surgery as a curative option should not be rejected even in this intermediate-risk cohort.

Keywords: infective endocarditis; prosthetic valve endocarditis; transcatheter aortic valve implantation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Case load of infective endocarditis from January 2013 to December 2020. NVE, native valve endocarditis; PVE, prosthetic valve endocarditis; SAVR–PVE, prosthetic valve endocarditis following surgical aortic valve replacement; TIE, prosthetic valve endocarditis following transcatheter aortic valve replacement.
Figure 2
Figure 2
Temporal distribution of aortic prosthetic valve endocarditis with the distribution of SAVR–PVE and TIE. (Data are expressed as percentages.) SAVR–PVE, prosthetic valve endocarditis following surgical aortic valve replacement; TIE, prosthetic valve endocarditis following transcatheter aortic valve replacement.
Figure 3
Figure 3
Kaplan–Meier survival curves of the SAVR–PVE group compared with the TIE group, with the number of patients at risk in tabular form. SAVR–PVE, prosthetic valve endocarditis following surgical aortic valve replacement; TIE, prosthetic valve endocarditis following transcatheter aortic valve replacement.
See this image and copyright information in PMC

References

    1. Habib G., Lancellotti P., Antunes M.J., Bongiorni M.G., Casalta J.P., Del Zotti F., Dulgheru R., El Khoury G., Erba P.A., Iung B., et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur. Heart J. 2015;36:3075–3123. doi: 10.1093/eurheartj/ehv319. - DOI - PubMed
    1. Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., Guyton R.A., O’Gara P.T., Ruiz C.E., Skubas N.J., Sorajja P., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American college of cardiology/American heart association task force on practice guidelines. J. Am. Coll. Cardiol. 2014;63:e57–e185. doi: 10.1016/j.jacc.2014.02.536. - DOI - PubMed
    1. Regueiro A., Linke A., Latib A., Ihlemann N., Urena M., Walther T., Husser O., Herrmann H.C., Nombela-Franco L., Cheema A., et al. Infective Endocarditis following Transcatheter Aortic Valve Replacement: Comparison of Balloon-Versus Self-Expandable Valves. Circ. Cardiovasc. Interv. 2019;12:e007938. doi: 10.1161/CIRCINTERVENTIONS.119.007938. - DOI - PubMed
    1. Summers M.R., Leon M.B., Smith C.R., Kodali S.K., Thourani V.H., Herrmann H.C., Makkar R.R., Pibarot P., Webb J.G., Leipsic J., et al. Prosthetic Valve Endocarditis after TAVR and SAVR: Insights from the PARTNER Trials. Circulation. 2019;140:1984–1994. doi: 10.1161/CIRCULATIONAHA.119.041399. - DOI - PubMed
    1. Brouwer J., van den Brink F.S., Nijenhuis V.J., Vossenberg T.N., Delewi R., van Mourik M.S., den Heijer P., Tanis W., Kievit P.C., Holvoet W., et al. Incidence and outcome of prosthetic valve endocarditis after transcatheter aortic valve replacement in the Netherlands. Neth. Heart J. 2020;28:520–525. doi: 10.1007/s12471-020-01420-2. - DOI - PMC - PubMed